Recalled heart devices often do not go through clinical testing, a new study found, highlighting growing concerns about the ...

Following Medtronic Inc.’s (NYSE:MDT) recent announcement that it had received CE Mark (Conformité Européenne) approval for the commercial sale of the Endeavor™ Drug-Eluting Coronary Stent ...

Key players include Medtronic, Abbott ... Segment Analysis The market is also divided by product type into coronary stents, peripheral stents, and EVAR stent grafts. Coronary stents lead the ...

India's largest stent manufacturer, Sahajanand Medical Technologies is also reportedly exploring a public listing on the domestic market ...

Medtronic Plc is a global leader in medical technology, offering a broad range of vascular stents designed for treating conditions such as endovascular aortic aneurysms and coronary artery disease.

The Standing National Committee on Medicines (SNCM), in its recommendation, included coronary stents in the NLEM, 2022 in two categories -- Bare Metal Stents (BMS) and Drug Eluting Stents (DES ...

Paid and presented by Medtronic. The growing application of digital health technologies is advancing the capabilities of insertable cardiac devices. The most recent iterations can connect to a ...

Summary: The use of balloon angioplasty with or without coronary artery stenting is limited by the phenomenon of in-stent restenosis (ISR). Until very recently, most efforts to overcome ISR had ...

Medtronic's cardiac and vascular unit accounted for $ ... including coils, neurovascular stents, and flow diversion products. Neuroscience also manufactures products related to implantable ...

Medtronic reported fiscal Q1 2025 EPS of $1.23, beating consensus estimates by 3 cents. Revenues rose 3.4% YoY to $7.97 billion, beating $7.90 billion consensus estimates. The company saw growth ...